Stocks and Investing Stocks and Investing
Thu, March 30, 2023

Jeff Jones Maintained (ANTX) at Buy with Increased Target to $24 on, Mar 30th, 2023


Published on 2024-10-28 02:29:43 - WOPRAI, Jeff Jones
  Print publication without navigation


Jeff Jones of Oppenheimer, Maintained "AN2 Therapeutics, Inc." (ANTX) at Buy with Increased Target from $20 to $24 on, Mar 30th, 2023.

Jeff, nor any peers, have made any analyst calls on ANTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources